TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Galena Biopharma Inc (NASDAQ: GALE) Investor Securities Class Action Lawsuit 03/06/2014

  • If you purchased shares of Galena Biopharma Inc (NASDAQ: GALE), you might have certain options and should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

November 21, 2017 - The court approved the settlement and entered the orders approving the plan of allocation, the motion for attorneys’ fees and expenses, and dismissing the action with prejudice. July 11, 2017 - The court ordered the authorization of the distribution of the net settlement fund. June 27, 2017 - The court preliminarily approved the settlement with remaining defendan...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: